Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of

Joy Dip Barua1, Shudeb Babu Sen Omit2, Humayan Kabir Rana3

  • 1Department of Pharmacy, BGC Trust University Bangladesh, Chattogram, Bangladesh.

Insights

This study reveals the genetic links between cardiovascular disease (CVD) and its risk factors like hypertension and diabetes. Findings identify key genes and pathways, aiding future CVD treatment strategies.

Area of Science:

  • Genomics
  • Computational Biology
  • Cardiovascular Research

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality, accounting for one-third of annual deaths worldwide.
  • Established risk factors exacerbate CVD, but their genetic associations remain underexplored in current literature.
  • This study investigates the intricate genetic linkages between CVD and its primary risk factors.

Purpose of the Study:

  • To computationally explore the genetic associations between cardiovascular disease (CVD) and its key risk factors.
  • To identify shared differentially expressed genes (DEGs), hub proteins, and biological pathways implicated in CVD.
  • To provide a foundation for further laboratory validation and the development of novel CVD therapeutic strategies.

Main Methods:

  • Utilized GEO microarray datasets to analyze gene expression patterns in CVD and associated risk factors.
  • Performed diseasome, protein-protein interaction (PPI), and pathway analyses to uncover molecular relationships.
  • Validated findings using established databases such as OMIM, dbGAP, and DisGeNET.

Main Results:

  • Identified overlapping DEGs between CVD and risk factors: hypertension (32), type 2 diabetes (17), hypercholesterolemia (53), obesity (70), and aging (89).
  • Discovered 10 major hub proteins (e.g., FPR2, TNF, CXCL8) and significant functional/gene ontological pathways associated with CVD.
  • Confirmed the genetic connections between CVD and its risk factors through gold benchmark databases.

Conclusions:

  • The computational approach successfully elucidated the genetic associations between CVD and its risk factors.
  • Identified significant DEGs, hub proteins, and pathways provide a basis for understanding CVD pathogenesis.
  • These findings offer potential targets for future laboratory research and the development of effective CVD treatments.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
442
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28